Gain Therapeutics, Inc. (GANX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.73M | -4.62M | -4.93M | -5.1M | -3.82M | -3.45M | -6.08M | -5.76M | -3.59M | -5.66M | -3.97M | -5.02M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -23.71% | -33.69% | 18.92% | 11.42% | -6.55% | 38.97% | -53.18% | -14.64% | 14.96% | -44.97% | -20.6% | 0.59% |
| Net Income | -5.61M | -4.54M | -5.28M | -5.81M | -4.53M | -3.77M | -4.49M | -8.14M | -4.01M | -4.72M | -4.72M | -7.69M |
| Depreciation & Amortization | 21.3K | 28.24K | 22.82K | 22.33K | 20.66K | 21.31K | 21.64K | 20.59K | 20.53K | 23.59K | 20.51K | 20.24K |
| Stock-Based Compensation | 0 | 401.67K | 460K | 522.02K | 419.5K | 359.33K | 357.5K | 1.48M | 190.42K | 555.06K | 907.33K | 1.23M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 633.97K | 11.19K | 10.86K | 673.29K | 109.59K | 553.98K | -44.18K | -166.13K | -200.15K | -135.7K | -171.11K | 45.85K |
| Working Capital Changes | 225.93K | -522.01K | -135.75K | -507.53K | 158.78K | -621.03K | -1.93M | 1.05M | 416.81K | -1.38M | -5.18K | 1.37M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 531.77K | -785.26K | -949.14K | 151.65K | 1.11M | -58.07K | -1.85M | 1.48M | 703.59K | -976.79K | -46.1K | -677.85K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -43.45K | -1 | 2M | 3.02M | 3.14M | 1.93M | 3.05M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -945 | -1 | -21.55K | 0 | -19 | -650 | -3.64K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 404.32K | 16.55M | 7.03M | 2.47M | 2.4M | 2.31M | 808.68K | 10.04M | -145.8K | 9.56M | 134.47K | 2.2M |
| Debt Issued (Net) | -25.52K | -25.02K | -25K | -24.24K | -22.24K | -22.78K | -23.12K | -22.11K | -22.87K | -22.58K | -22.63K | -22.25K |
| Equity Issued (Net) | 429.85K | 16.58M | 7.41M | 2.49M | 2.42M | 2.34M | 831.79K | 10.04M | 157.94K | 9.58M | 157.1K | 2.22M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -353.73K | 0 | 0 | -1 | 1 | 13.57K | -280.87K | 0 | 0 | 0 |
| Net Change in Cash | -4.3M | 12.03M | 2.11M | -2.37M | -1.31M | -1.67M | -4.88M | 6.3M | -1.15M | 7.53M | -2.05M | 332.42K |
| Free Cash Flow | -4.73M | -4.62M | -4.93M | -5.1M | -3.82M | -3.46M | -6.08M | -5.78M | -3.59M | -5.66M | -3.97M | -5.03M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -23.71% | -33.65% | 18.92% | 11.75% | -6.55% | 38.95% | -53.15% | -14.98% | 15.18% | -44.62% | -18.56% | 1.39% |
| FCF per Share | -0.11 | -0.14 | -0.14 | -0.17 | -0.13 | -0.13 | -0.23 | -0.30 | -0.20 | -0.35 | -0.31 | -0.41 |
| FCF Conversion (FCF/Net Income) | 0.84x | 1.02x | 0.93x | 0.88x | 0.84x | 0.92x | 1.35x | 0.71x | 0.89x | 1.20x | 0.84x | 0.65x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |